The microbiome and intestinal mucosal immunity: a therapeutic target to alleviate neuroinflammation in autism spectrum disorders
| dc.rights.license | CC-BY-NC-ND | |
| dc.contributor.advisor | Perez-Pardo, P. | |
| dc.contributor.author | Halabi, Youmna Al | |
| dc.date.accessioned | 2022-02-08T01:00:34Z | |
| dc.date.available | 2022-02-08T01:00:34Z | |
| dc.date.issued | 2022 | |
| dc.identifier.uri | https://studenttheses.uu.nl/handle/20.500.12932/472 | |
| dc.description.sponsorship | Utrecht University | |
| dc.language.iso | EN | |
| dc.subject | The proposal describes the use of prebiotics, probiotics and synbiotics to target the gut microbiome. The gut microbiome plays a crucial role in influencing the gut-brain-axis (GBA) and the development of mucosal immunity. In autism spectrum disorders (ASD), alterations in the microbiome have been reported which has been linked to cytokine aberrations. We propose that targeting mucosal immunity and the microbiome of the intestines will alleviate neuroinflammation in the ASD brain. | |
| dc.title | The microbiome and intestinal mucosal immunity: a therapeutic target to alleviate neuroinflammation in autism spectrum disorders | |
| dc.type.content | Master Thesis | |
| dc.rights.accessrights | Open Access | |
| dc.subject.courseuu | Drug Innovation | |
| dc.thesis.id | 2154 |
